Massively parallel analysis of genotype-dependent enhancer activity among atopic dermatitis genetic risk variants
Journal of Allergy and Clinical Immunology · 2025-12 · 156 (6) · 1600-1613
DOI: 10.1016/j.jaci.2025.07.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025-12. Verfasst von Molly S Shook und 18 weiteren Autor:innen. Beteiligte Einrichtung: Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Enhancer Elements, Genetic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NINDS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Atopic dermatitis (AD) is an inflammatory, pruritic disease of the skin with a complex etiology involving environmental and genetic factors. Numerous genetic risk loci for AD have been nominated through genome-wide association studies, with most associated variants residing in noncoding regions. Further work is needed to understand how genetic variation contributes to disease-related alterations to gene expression. OBJECTIVE: We sought to use massively parallel reporter assays to identify genetic risk variants with genotype-dependent regulatory activity within a set of 2,381 variants distributed among 49 independent AD risk loci. METHODS: We used our massively parallel reporter assay library in HaCaT skin keratinocytes, TE-7 esophageal epithelial cells, and Jurkat T cells, enabling the identification of shared and cell-type-specific variants with genotype-dependent enhancer activity. Stimulation of HaCaT and TE-7 cells with the cytokine IL-13 revealed 14 variants with stimulation-dependent allelic expression patterns. RESULTS: Our approach discovered 96 allelic enhancer variants among all investigated cellular contexts, representing 32 independent AD risk loci. We discover a possible mechanistic role for activator protein 1 family transcription factors, as revealed by motif enrichment, genotype-dependent binding, and enhanced chromatin immunoprecipitation sequencing signal at AD risk variants with allelic enhancer activity compared with variants with nonallelic enhancer activity. We assign allelic enhancer variants to probable target genes, including previously identified risk genes such as KIF3A and FLG. CONCLUSIONS: Our systematic, genome-scale approach implicates causal genotype-dependent gene regulatory mechanisms for most AD risk loci, providing a unique resource for the discovery of the genetic mechanisms underlying this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
- Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
- Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio; Division of Immuno…
- Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio.
- Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
- Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio; Division of Human…
Förderung
- NIAID NIH HHS
- NINDS NIH HHS
- NIDDK NIH HHS
- NHGRI NIH HHS
- NIGMS NIH HHS
- NIAMS NIH HHS
- Cincinnati Children's Hospital Medical Center
- National Institutes of Health
Zitieren
APA
Shook, M. S., Lu, X., Chen, X., Edsall, L. E., Granitto, M., Virolainen, S. J., Forney, C., Donmez, O. A., Parameswaran, S., Fadden, C., Dexheimer, P. J., Jenkins, S., Grashel, B., Kaufman, K. M., Hershey, G. K., Martin, L. J., Satish, L., Weirauch, M. T., & Kottyan, L. C. (2025). Massively parallel analysis of genotype-dependent enhancer activity among atopic dermatitis genetic risk variants. Journal of Allergy and Clinical Immunology, 156(6), 1600-1613. https://doi.org/10.1016/j.jaci.2025.07.032
Vancouver
Shook MS, Lu X, Chen X, Edsall LE, Granitto M, Virolainen SJ, et al. Massively parallel analysis of genotype-dependent enhancer activity among atopic dermatitis genetic risk variants. Journal of Allergy and Clinical Immunology. 2025;156(6):1600-1613. doi:10.1016/j.jaci.2025.07.032
BibTeX
@article{Shook2025,
author = {Shook, Molly S and Lu, Xiaoming and Chen, Xiaoting and Edsall, Lee E and Granitto, Marissa and Virolainen, Samuel J and Forney, Carmy and Donmez, Omer A and Parameswaran, Sreeja and Fadden, Catherine and Dexheimer, Phillip J and Jenkins, Seth and Grashel, Brittany and Kaufman, Kenneth M and Hershey, Gurjit Khurana and Martin, Lisa J and Satish, Latha and Weirauch, Matthew T and Kottyan, Leah C},
title = {Massively parallel analysis of genotype-dependent enhancer activity among atopic dermatitis genetic risk variants},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
volume = {156},
number = {6},
pages = {1600--1613},
doi = {10.1016/j.jaci.2025.07.032}
}
EUVIMED